
FDA Grants Orphan Status to Liquid Glioma Treatment SH-110
The U.S. Food and Drug Administration (FDA) granted orphan drug designation to SH-110, a liquid medication designed to treat glioma, a rare form of brain cancer, in patients who have trouble swallowing pills. “For too long, many patients with glioma and …